These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6139836)

  • 1. Platelet aggregation response in schizophrenia and prostaglandin E1.
    Kaiya H; Imai H; Muramatsu Y; Nozaki M; Fujimura H; Adachi S; Namba M
    Psychiatry Res; 1983 Aug; 9(4):309-18. PubMed ID: 6139836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal platelet aggregation response in Huntington's disease.
    Muramatsu Y; Kaiya H; Imai H; Nozaki M; Fujimura H; Namba M
    Arch Psychiatr Nervenkr (1970); 1982; 232(3):191-200. PubMed ID: 6218794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog.
    Johnson GJ; Rao GH; Leis LA; White JG
    Blood; 1980 May; 55(5):722-9. PubMed ID: 6244866
    [No Abstract]   [Full Text] [Related]  

  • 4. ADP and arachidonic acid induced platelet aggregation in schizophrenia and atypical psychoses.
    Whalley LJ; Reading HW; Rosie R
    Psychol Med; 1984 Feb; 14(1):207-11. PubMed ID: 6143339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E1 suppression of platelet aggregation response in schizophrenia.
    Kaiya H
    Schizophr Res; 1991; 5(1):67-80. PubMed ID: 1854678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K; Huzoor-Akbar
    Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
    Halushka PV; Lurie D; Colwell JA
    N Engl J Med; 1977 Dec; 297(24):1306-10. PubMed ID: 917087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
    Teng CM; Ma YH; Ouyang CH
    Biochim Biophys Acta; 1985 Jul; 841(1):8-14. PubMed ID: 3926005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate).
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 Feb; 75(2):257-9. PubMed ID: 6892270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients.
    McAdams C; Leonard BE
    Int Clin Psychopharmacol; 1992 Nov; 7(2):81-5. PubMed ID: 1487625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY; McGiff JC; Sun FF; Lee WH
    Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the equine platelet aggregation response.
    Meyers KM; Lindner C; Grant B
    Am J Vet Res; 1979 Feb; 40(2):260-4. PubMed ID: 464363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients.
    Orr MW; Knox JM; Allen R; Gelder MG; Grahame-Smith DG
    Br J Clin Pharmacol; 1981 Mar; 11(3):255-9. PubMed ID: 6111333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of inhibitors of platelet release and aggregation.
    Rosenberg JC; Sell TL
    Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between dipyridamole and prostaglandin E1 with ADP-induced aggregation of rat platelet in whole blood.
    Touqui L; Hatmi M; Vargaftig BB
    Thromb Haemost; 1984 Jul; 51(3):410. PubMed ID: 6541815
    [No Abstract]   [Full Text] [Related]  

  • 17. [Platelet aggregation in patients with atopic bronchial asthma].
    Kotlinowska T
    Pol Tyg Lek; 1982 Nov; 37(41-42):1237-40. PubMed ID: 7163072
    [No Abstract]   [Full Text] [Related]  

  • 18. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-tocopherol: its inhibition on human platelet aggregation.
    Fong JS
    Experientia; 1976 May; 32(5):639-41. PubMed ID: 1278322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.